Pages that link to "Q37683975"

The following pages link to Acute viral bronchiolitis in children- a very common condition with few therapeutic options (Q37683975):

Displaying 40 items.

• Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old (Q24186176) (← links)
• Bronchodilators for bronchiolitis (Q24193936) (← links)
• Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old (Q24203734) (← links)
• Bronchodilators for bronchiolitis (Q24235615) (← links)
• Hypertonic Saline for the Treatment of Bronchiolitis in Infants and Young Children: A Critical Review of the Literature (Q26753153) (← links)
• Genetic association of TLR4 Asp299Gly, TLR4 Thr399Ile, and CD14 C-159T polymorphisms with the risk of severe RSV infection: a meta-analysis (Q26768424) (← links)
• Etiology, Seasonality, and Clinical Features of Viral Respiratory Tract Infections in Children Hospitalized With Acute Bronchiolitis: A Single-Center Study (Q33834523) (← links)
• Infection-induced wheezing in young children (Q33862271) (← links)
• Therapeutic approach to bronchiolitis: why pediatricians continue to overprescribe drugs? (Q34221130) (← links)
• Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants (Q34462915) (← links)
• Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age. (Q34531856) (← links)
• Development of a questionnaire to assess the impact on parents of their infant's bronchiolitis hospitalization (Q34816358) (← links)
• β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids (Q35621371) (← links)
• Nebulised hypertonic saline (3%) among children with mild to moderately severe bronchiolitis--a double blind randomized controlled trial (Q35769688) (← links)
• β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study (Q35775111) (← links)
• The role of zinc sulfate in acute bronchiolitis in patients aged 2 to 23 months (Q36244794) (← links)
• Viral aetiology of bronchiolitis in hospitalised children in Qatar. (Q36279043) (← links)
• Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study. (Q36676407) (← links)
• Validation of a scale to assess the severity of bronchiolitis in a population of hospitalized infants (Q37724817) (← links)
• Gender Specific Differences in the Immune Response to Infection (Q37858452) (← links)
• The microarray technology: facts and controversies. (Q38049183) (← links)
• Viral bronchiolitis in children: a common condition with few therapeutic options. (Q38131084) (← links)
• Vitamin D receptor (VDR) polymorphisms and severe RSV bronchiolitis: a systematic review and meta-analysis. (Q38135780) (← links)
• Acute bronchiolitis in infants, a review (Q38201518) (← links)
• Recent advances in the management of acute bronchiolitis (Q38314877) (← links)
• Non-invasive ventilation is useful in paediatric intensive care units if children are appropriately selected and carefully monitored (Q38511897) (← links)
• Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor (Q38650711) (← links)
• Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Epinephrine and Corticosteroid Therapy for Acute Bronchiolitis in Infants. (Q38687445) (← links)
• IV Magnesium Sulfate for Bronchiolitis: A Randomized Trial. (Q38912257) (← links)
• A systematic review of the psychometric properties of bronchiolitis assessment tools. (Q38923691) (← links)
• A regional cohort study of the treatment of critically ill children with bronchiolitis (Q39768481) (← links)
• Infants under 6 months with bronchiolitis are most likely to need major medical interventions in the 5 days after onset (Q40205925) (← links)
• Treatment of acute viral bronchiolitis (Q40413229) (← links)
• Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort. (Q42270216) (← links)
• Controversies in the Treatment of the Acutely Wheezing Infant (Q42755620) (← links)
• Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis. (Q45242662) (← links)
• Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. (Q45264827) (← links)
• Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system (Q45358352) (← links)
• La bronchiolite : recommandations pour le diagnostic, la surveillance et la prise en charge des enfants de un à 24 mois. (Q55641426) (← links)
• Pharmacokinetics, Safety and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized with RSV Infection: A Randomized Phase 1b Study (Q90580234) (← links)